Company News
Meet ALLpaQ’s Business Development Managers
At ALLpaQ, we understand that the greatest resource of any successful business is its people, and we’re excited to welcome […]
Jul 16th, 2024
The Medicine and Healthcare products Regulatory Agency has underscored the need for strong controls around extractables and leachables in pharmaceutical development.
Dr Melaine Pires, senior pharmaceutical assessor at the MHRA, outlined existing regulatory guidelines to delegates at the Disposable Solutions for Biomanufacturing Conference in Munich, Germany.
Risks surrounding extractables and leachables included interfering with drug efficacy.
As such, Dr Pires said discussions were underway to harmonise legislation in key drug development regions around the world.